{"bill":{"bill_id":1205735,"change_hash":"fa576c42f1a5464e373c519579910924","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB516\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/516\/all-info","completed":0,"status":1,"status_date":"2019-02-14","progress":[{"date":"2019-02-14","event":1},{"date":"2019-02-14","event":9}],"state":"US","state_id":52,"bill_number":"SB516","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"Prescription Drug Monitoring Act of 2019","description":"Expands the notification and reporting requirements with respect to potentially addictive prescription drugs for states receiving funds for a Prescription Drug Monitoring Program (PDMP). Dispensers of these drugs, which includes substances listed in schedule II, III, or IV of the Controlled Substances Act, must consult with the PDMP before starting treatment involving such drugs and report each prescription of such drugs to the PDMP within 24 hours.The state agency administering a PDMP must analyze reported data for patterns of controlled substance misuse or abuse and provide certain information to law enforcement, the public, and other states.","pending_committee_id":2328,"committee":{"committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"},"referrals":[{"date":"2019-02-14","committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"}],"history":[{"date":"2019-02-14","action":"Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9408,"person_hash":"r7nps3ip","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Amy Klobuchar","first_name":"Amy","middle_name":"","last_name":"Klobuchar","suffix":"","nickname":"","district":"SD-MN","ftm_eid":17659011,"votesmart_id":65092,"opensecrets_id":"N00027500","knowwho_pid":248506,"ballotpedia":"Amy_Klobuchar","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":11966,"person_hash":"d5cx9z5s","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"Rob Portman","first_name":"Rob","middle_name":"","last_name":"Portman","suffix":"","nickname":"","district":"SD-OH","ftm_eid":3094681,"votesmart_id":27008,"opensecrets_id":"N00003682","knowwho_pid":159002,"ballotpedia":"Rob_Portman","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":15348,"person_hash":"ov53d9s8","party_id":"3","state_id":52,"party":"I","role_id":2,"role":"Sen","name":"Angus King","first_name":"Angus","middle_name":"S.","last_name":"King","suffix":"Jr.","nickname":"","district":"SD-ME","ftm_eid":1792907,"votesmart_id":22381,"opensecrets_id":"N00034580","knowwho_pid":209655,"ballotpedia":"Angus_King","sponsor_type_id":2,"sponsor_order":3,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":9625,"person_hash":"7pac6cxl","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Joe Manchin","first_name":"Joe","middle_name":"","last_name":"Manchin","suffix":"III","nickname":"","district":"SD-WV","ftm_eid":7573477,"votesmart_id":7547,"opensecrets_id":"N00032838","knowwho_pid":219013,"ballotpedia":"Joe_Manchin_III","sponsor_type_id":2,"sponsor_order":4,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"HB3974","sast_bill_id":1272199}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13374,"subject_name":"Criminal justice information and records"},{"subject_id":13345,"subject_name":"Drug trafficking and controlled substances"},{"subject_id":13210,"subject_name":"Health information and medical records"},{"subject_id":13211,"subject_name":"Health personnel"},{"subject_id":13231,"subject_name":"Intergovernmental relations"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13507,"subject_name":"Medical ethics"},{"subject_id":13490,"subject_name":"Prescription drugs"},{"subject_id":13285,"subject_name":"State and local government operations"}],"texts":[{"doc_id":1951621,"date":"2019-03-07","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB516\/id\/1951621","state_link":"https:\/\/www.congress.gov\/116\/bills\/s516\/BILLS-116s516is.pdf","text_size":278399,"text_hash":"48cbe53d19ba57ca97a6faf07ac30761"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}